Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ.

J Natl Cancer Inst. 2001 May 16;93(10):783-9.

2.

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies.

Chan JM, Stampfer MJ, Giovannucci E, Ma J, Pollak M.

Growth Horm IGF Res. 2000 Apr;10 Suppl A:S32-3. Review. No abstract available.

PMID:
10984284
3.

[Obesity and a risk of carcinoma].

Payer J, Jackuliak P, Nagyová M.

Vnitr Lek. 2010 Oct;56(10):1082-7. Review. Slovak.

PMID:
21105457
4.

What causes prostate cancer? A brief summary of the epidemiology.

Chan JM, Stampfer MJ, Giovannucci EL.

Semin Cancer Biol. 1998 Aug;8(4):263-73. Review.

PMID:
9870033
5.

Acromegaly and prostate cancer.

Colao A, Marzullo P, Spiezia S, Lombardi G.

Growth Horm IGF Res. 2000 Apr;10 Suppl A:S37-8. Review. No abstract available.

PMID:
10984287
6.

Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.

Stolzenberg-Solomon RZ, Newton CC, Silverman DT, Pollak M, Nogueira LM, Weinstein SJ, Albanes D, Männistö S, Jacobs EJ.

Am J Epidemiol. 2015 Aug 1;182(3):187-97. doi: 10.1093/aje/kwv041. Review.

7.

Serum leptin levels may be correlated with cerebral infarction.

Li KB, Yao XL, Sun PG, Wu ZY, Li XX, Liu JQ, Li YL.

J Res Med Sci. 2016 Jan 28;21:4. Review.

Items per page

Supplemental Content

Support Center